期刊文献+

雌激素受体及孕激素受体在肝内及肝外胆管癌中的表达

Expression of estrogen receptor and progesterone receptor in intrahepatic and extrahepatic cholangiocarcinoma
原文传递
导出
摘要 目的对比研究雌激素受体(ER)、孕激素受体(PR)在肝内、外胆管癌中的表达情况。方法应用免疫组织化学法,检测24例肝内胆管癌和34例肝外胆管癌组织中ER和PR的表达水平。结果在肝内胆管癌中,ER和PR的阳性表达率分别为29%(7/24)和46%(11/24),组织学分级高分化组的9例中3例ER阳性表达,中分化组的11例中3例阳性表达,低分化组的4例中1例阳性表达;不同分级中,PR阳性表达分别为2、7、2例,各组织学分级间ER和PR的表达差异无统计学意义(均P〉0.05)。ER和PR在34例肝外胆管癌中均呈阴性表达。结论ER和PR在肝内、外胆管癌中的表达水平明显不同,仅表达于肝内胆管癌,可能参与了肝内胆管癌的发生过程。 Objective To investigate the expression of estrogen receptor (ER) and progesterone receptor (PR) in intrahepatic cholangiocarcinoma (ICCA) and extrahepatic cholangiocarcinoma (ECCA) comparatively. Methods The expression of ER and PR was detected in 24 specimens of ICCA and 34 specimens of ECCA by immunohistochemistry assay. Results The positive rates for ER and PR expression were 29 % (7/24) and 46 % (11/24) in ICCA specimens, respectively. 3 cases among 9 cases of high histological grade, 3 cases among l 1 cases of middle histological grade and 1 case among 4 cases of low histological grade expressed ER positively, while 2 cases, 7 cases and 2 cases expressed PR positively, respectively. The expression of ER and PR expressions showed no statistically significant differences between different histological grades of ICCA. ER and PR were all negative in 34 specimens of ECCA. Conclusion ER and PR show significant different expression between ICCA and ECCA, With exclusive positive expression in ICCA. ER and PR might be involved in the pathogenesis of ICCA.
出处 《肿瘤研究与临床》 CAS 2011年第12期817-818,828,共3页 Cancer Research and Clinic
关键词 胆管肿瘤 受体 雌激素 孕激素受体 Bile duct neoplasms Receptor, estrogen Progestins receptor
  • 相关文献

参考文献10

  • 1Gores GJ. Cholangiocarcinoma: current concepts and insights. Hepatology, 2003, 37:961-969.
  • 2Shaib Y, E1-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis, 2004, 24:115-125.
  • 3杨京平,张伟,柳剑英.ER和PR在“非性激素靶器官”表达的免疫组化观察[J].诊断病理学杂志,2000,7(1):21-23. 被引量:7
  • 4Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med, 2010, 134: 907-922.
  • 5A|varo D, Barbaro B, Franchitto A, et al. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol, 2006, 169: 877-888.
  • 6范正军,吴阳,王志军.雌、孕激素受体在肝门部胆管癌中的表达及意义[J].中华医学杂志,2005,85(37):2651-2653. 被引量:7
  • 7雷元卫,陈廷暄.胆管癌性激素受体的表达及其临床病理学意义[J].湖北省卫生职工医学院学报,2004,17(3):5-7. 被引量:4
  • 8Mancino A, Mancino MG, Glaser SS, et al. Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. Dig Liver Dis, 2009, 41: 156-163.
  • 9Tang D, Nagano H, Yamamoto H, et al. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2,thrombospondin-I arid clinicopathological significance. Oncol Rep, 2006, 15: 525-532.
  • 10刘志华,陈筠,贺艳平.他莫昔芬联合化疗对胆管癌耐药细胞株QBC939/ADM的影响[J].肿瘤研究与临床,2008,20(11):734-736. 被引量:3

二级参考文献24

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部